NICE recommends first licensed treatment for vitiligo
Abstract
The National Institute for Health and Care Excellence (NICE) has recommended the first treatment that “effectively treats” the skin condition vitiligo for use on the NHS in England. In final draft guidance, published on 24 February 2026, NICE approved ruxolitinib cream (Opzelura; Incyte), applied twice daily, for patients with vitiligo who are aged 12 years […]
Fields of Study & Subjects
melanin and skin pigmentation
Dermatology and Skin Diseases
Dermatologic Treatments and Research
Publication details
- Journal / source
- Pharmaceutical journal/The pharmaceutical journal
- Publication date
- 1 January 2026
- Language
- EN